Stereotaxis Inc - Ordinary Shares

Stereotaxis Inc - Ordinary Shares is not very popular among insiders. Stereotaxis Inc - Ordinary Shares is a mediocre stock to choose.
Log in to see more information.

News

Stereotaxis to Present at Upcoming Investor Conferences
Stereotaxis to Present at Upcoming Investor Conferences

Globe Newswire ST. LOUIS, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...\n more…

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Globe Newswire ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its...\n more…

Stereotaxis Reports 2024 Second Quarter Financial Results
Stereotaxis Reports 2024 Second Quarter Financial Results

Globe Newswire ST. LOUIS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...\n more…

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Globe Newswire Latest innovation in Robotic Magnetic Navigation technology supports broad accessibility of robotics for minimally-invasive endovascular surgeryGenesisX has obtained CE mark in Europe and has been...\n more…

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

Globe Newswire ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...\n more…

Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

Globe Newswire ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...\n more…